Glaukos Corporation

-0.23 (-0.43%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.52B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$67.81 Million
Adjusted EPS-$0.53
See more estimates
10-Day MA$53.11
50-Day MA$52.42
200-Day MA$50.32
See more pivots

Glaukos Corporation Stock, NYSE:GKOS

229 Avenida Fabricante, 229 Avenida Fabricante, San Clemente, California 92672
United States of America
Phone: +1.949.367.9600
Number of Employees: 727


Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.